Modulation of antibody response in a sensitized patient with ongoing antibody-mediated injury

Clin Transpl. 2009:495-8.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • ABO Blood-Group System
  • Adult
  • Boronic Acids / therapeutic use*
  • Bortezomib
  • Female
  • HLA Antigens / immunology
  • HLA-DQ Antigens / drug effects
  • HLA-DQ Antigens / immunology
  • HLA-DR Antigens / drug effects
  • HLA-DR Antigens / immunology
  • HLA-DRB4 Chains
  • Histocompatibility Testing
  • Humans
  • Immunosuppressive Agents
  • Isoantibodies / blood*
  • Kidney Diseases / etiology
  • Kidney Diseases / surgery*
  • Kidney Transplantation / immunology*
  • Lupus Erythematosus, Systemic / complications
  • Male
  • Protease Inhibitors / therapeutic use*
  • Pyrazines / therapeutic use*
  • Reoperation
  • Siblings
  • Tissue Donors
  • Treatment Failure

Substances

  • ABO Blood-Group System
  • Boronic Acids
  • HLA Antigens
  • HLA-DQ Antigens
  • HLA-DQ2 antigen
  • HLA-DR Antigens
  • HLA-DR53
  • HLA-DRB4 Chains
  • Immunosuppressive Agents
  • Isoantibodies
  • Protease Inhibitors
  • Pyrazines
  • Bortezomib